BIVDA Press Releases

Press Release - BIVDA responds to the Government’s £248 million investment to modernise diagnostics -- Nearly £250 million is to be injected by the Government into the modernisation of diagnostic care across the NHS. This will lead to improved technology, data sharing, accelerate routine care and, crucially, help tackle significant care backlogs.  Delivering more diagnostic tests, health checks and scans is non-negotiable for the UK population’s health...

-- For Immediate Release BIVDA, the UK’s leading association for In Vitro Diagnostics (IVD) technology and innovation, responds to today’s Budget announcements, outlined in the House of Commons by Chancellor Rishi Sunak. This Budget comes at a crucial moment regarding protecting the UK’s health service through the winter as it tackles backlogs and readies itself for future public health threats. The Government must recognise the role of both the home-grown d...

For Immediate Release--- The British In Vitro Diagnostics Association is calling for this Spending Review to invest in key enablers to support the UK diagnostic sector’s capacity to tackle care backlogs, drive innovation and prepare for potential future pandemics. Building a diagnostics sector that is pandemic-ready and can support the UK’s healthcare needs requires stronger UK manufacturing, innovation, a highly skilled workforce and support for companies becoming more sustaina...

BIVDA is pleased to support Associations Week 2021, an initiative that shines a spotlight on the work of professional associations and to celebrate the people, employees and volunteers who make associations work. The campaign takes place from 27-30 September, with networking events, a pivot fest and a focus on sustainability, EDI. BIVDA is the national industry association for the manufacturers and distributors of in vitro diagnostic (IVD) products in the UK. As an organisation we represent 95% ...

BIVDA has released a statement on the recent Blood Collection Tube shortages being faced by the medical sector and NHS. Please find the downloadable file below.

Please see the below quote from BIVDA regarding exemptions for key workers regarding COVID-19 app alerts:  "BIVDA welcomes flexibility for essential workers in exceptional circumstances and is looking forward to receiving further guidance from the Government on the process involved. Fast, decisive action is key in circumstances such as this and we support the action taken to prevent further issues. We know this may not have gone as far as many of our member companies would wi...

BIVDA Comments on new Innovation Strategy BIVDA Chief Executive Doris-Ann Williams has commented on the Government’s new Innovation Strategy, which aims to put Britain at the front of the global race to attract world-leading science expertise, highly skilled jobs and new products.According to the Government, the UK is committed to increasing annual public investment on R&D to £22 billion. The private sector also plays a key role in boosting spending on R&D, which is an e...

BIVDA has partnered with Zinc Media to produce a series of documentary-format programs, focusing on the in vitro diagnostics sector, and showcasing powerful examples of the value that IVD’s bring to healthcare.   The content series will look at IVD’s role in the current pandemic and how this manifests into preparedness for future pandemics, the importance of IVDs in tackling the antimicrobial resistance challenge, along with sustainability and how the industry plans to redu...

Professional Accredited Registration (‘Credentialing’) is supported by BIVDA, but the use of appointment systems increases risk and delay in services and incurs un-necessary cost for suppliers.  BIVDA (British In Vitro Diagnostics Association) is the national industry association for the manufacturers and distributors of in vitro (IVD) products in the UK, representing almost 200 organisations including multi-nationals and SME’s.  BIVDA members supply products, equipme...

BIVDA launches its Sustainability Training Programme for members in partnership with SGS.   Sustainability is a key issue of operational transformation that the in-vitro diagnostics (IVD) sector must take heed of in light of the NHS Net Zero requirements, corporate social responsibility (CSR) and the duty we share to conserve the environment. As the trade association for the IVD sector, BIVDA is pleased to be able to help empower and facilitate member companies on their journey towards...